CHINA PHARMA HOLDINGS, INC. (ticker: CPHI) is an NYSE-listed pharma company. DredgeCap's structured extraction of CPHI's SEC filings surfaces 15 active risk signals, including 14 late-filing signals, and 1 auditor-change signal. CPHI reported $4.14M in revenue and -$3.19M for the period ending 2025-12-31, with operating cash flow of $148K. Cash and equivalents stood at $345K (down 44.9% year-over-year). Total assets of $31.00M exceed total liabilities of $8.26M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
CPHI Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for CHINA PHARMA HOLDINGS, INC. (CPHI) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.